Skip to main content
. 2021 Jul 6;13(14):3393. doi: 10.3390/cancers13143393

Table 2.

Dysregulation of expression of invasiveness-associated miRNAs in endometrial cancer.

MiRNA Human Tissue Cell Line Circulating miRNA Ref. MiRNA Human Tissue Cell Line Circulating miRNA Ref.
let-7b n/d [41] miR-10b * n/d [118,129]
miR-1 n/d [97] miR-21 n/d n/d [57,75,107]
miR-10b * n/d n/d [38,78] miR-27 n/d [60]
miR-20a-5p n/d [40] miR-34a * n/d n/d [61]
miR-20b-5p n/d [116] miR-93 n/d n/d [27]
miR-22 n/d [77,121] miR-93-5p n/d [95,105]
miR-23a n/d [118,128] miR-95 n/d [110]
miR-26a n/d n/d [42] miR-99a n/d n/d [76]
miR-29a-5p n/d [44] miR-100 n/d n/d [76]
miR-29b n/d [24,38,81] miR-106a n/d [73]
miR-30c n/d n/d [96] miR-107-5p n/d [19]
miR-34 n/d n/d [57] miR-130b * n/d n/d [122]
miR-34a * n/d n/d [34] miR-141 n/d [35,47,77]
miR-34b n/d n/d [38,39,101] miR-145 n/d n/d [21]
miR-34c n/d n/d [43,123] miR-146a n/d n/d [114]
miR-99a n/d n/d [51,76] miR-148b n/d n/d [57]
miR-100 n/d n/d [76] miR-181a n/d n/d [37]
miR-101 n/d [38,46,56,106,119] miR-182 n/d n/d [30,47,48,77]
miR-124 n/d n/d [33,50,99] miR-183 n/d n/d [30,48,62,77,92]
miR-125 n/d n/d [57] miR-192 n/d n/d [30]
miR-125b n/d n/d [63,104] miR-194 n/d n/d [30]
miR-126 n/d n/d [109,120] miR-200a n/d [35,48,77,102]
miR-130b * n/d n/d [32] miR-200b n/d n/d [31,77,102]
miR-133a n/d [38,97] miR-200c n/d [26,47,48,53,77]
miR-133b n/d n/d [38] miR-203 n/d [77]
miR-136 n/d n/d [65] miR-205* n/d n/d [29,30,35,38,47,48,59,68,77,78,89,91]
miR-139-5p n/d n/d [54] miR-210 n/d n/d [100]
miR-142 n/d n/d [69] miR-218 * n/d n/d [30]
miR-143 [22] miR-222-3p n/d [47,52]
miR-144-3p n/d [85] miR-301 n/d n/d [57]
miR-152 n/d n/d [38] miR-373 n/d [49,99]
miR-183-5p n/d n/d [98] miR-429 n/d n/d [77,102]
miR-184 n/d n/d [28] miR-449 n/d n/d [30]
miR-195 n/d [78,108] miR-449a n/d n/d [77]
miR-196a n/d n/d [23] miR-486-5p n/d [112]
miR-199a-3p n/d n/d [90] miR-494-3p n/d n/d [117]
miR-199a/b-5p n/d [93] miR-499 n/d n/d [78]
miR-202 n/d [25,94] miR-522 n/d [132]
miR-204 n/d n/d [18,30] miR-544a n/d [111]
miR-205 * n/d n/d [110,118] miR-652 n/d n/d [72]
miR-206 n/d [124] miR-940 n/d [115]
miR-214-3p n/d [36,82] miR-1202 n/d n/d [23]
miR-218 * n/d [125] miR-1228 n/d n/d [77]
miR-219-5p n/d n/d [87]
miR-301b n/d n/d [77]
miR-302a-5p n/d n/d [126]
miR-302c-3p n/d n/d [67]
miR-320a n/d n/d [103]
miR-326 n/d [55]
miR-340-5p n/d n/d [103]
miR-361 n/d [41]
miR-363 n/d [83]
miR-365 n/d [80]
miR-367-3p n/d n/d [126]
miR-372 n/d n/d [130]
miR-381 n/d [79]
miR-424 n/d [34,58,66]
miR-449a n/d n/d [127]
miR-490-3p n/d n/d [64,70]
miR-499a n/d [45]
miR-505 n/d n/d [131]
miR-513 n/d n/d [34]
miR-543 n/d [20]
miR-548c n/d n/d [71]
miR-589-5p n/d n/d [86]
miR-646 n/d [113]
miR-873 n/d [84]
miR-1271-5p n/d [74,88]

↓—downregulated in endometrial cancer compared to normal cells, ↑—upregulated in endometrial cancer compared to normal cells, n/d—no data, *—inconsistent data of miRNAs expression.